Skip to main content
Fig. 2 | BMC Microbiology

Fig. 2

From: Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients

Fig. 2

Characteristics of the microbial composition in SLE patients with PPI use. A Relative abundance of the dominant bacteria at phylum level in the gut microbiota of SLE patients with or without PPIs use and the HCs group; B Relative abundance of the dominant bacteria at phylum level in the gut microbiota of SLE patients with or without PPIs use and the HCs group; C Relative abundance of the dominant bacteria at genus level in the gut microbiota of SLE patients with or without PPIs use and the HCs group. HCs: healthy controls; P-SLE: SLE patients with PPIs; NP-SLE: SLE patients without PPIs

Back to article page